Products

 

U.S. GAO - End-Stage Renal Disease: CMS Should Monitor Access to and Quality of Dialysis Care

GAO: Recommendations for Executive Action:.....Recommendation: To help ensure that changes in Medicare payment methods for dialysis care do not adversely affect beneficiaries, the Administrator of CMS should monitor the access to and quality of dialysis care for groups of beneficiaries,

U.S. GAO - End-Stage Renal Disease: CMS Should Assess Adequacy of Payment When Certain Oral Drugs

GAO: This report (1) describes the rationales for including oral-only ESRD drugs in the bundled payment, (2) examines dialysis organizations' recent experience providing oral-only ESRD drugs and their future ability to provide these drugs, (3) examines the data sources that CMS could use to account

Skilled nursing care facilities in UK

Skilled nursing care facilities - UK

Nursing Care Facilities in US

Nursing Care Facilities - US

Nursing Care Facilities in Ireland

Nursing Care Facilities - Ireland

ResMed - vpap_series

United States & Canada > Change Location About Us Contact Us Careers Home Patients & Families Clinicians Commercial Partners Investors Text size vpap_series Noninvasive Ventilation ResMed NIV NIV Series From Hospital to Home Medicare NIV Reimbursement Resources Learn how ResMed’s NIV technology

ResMed - vpap_series

United States & Canada > Change Location About Us Contact Us Careers Home Patients & Families Clinicians Commercial Partners Investors Text size vpap_series VPAP Series Learn about VPAP VPAP Series Specifications Medicare VPAP Reimbursement Resources Improving patient compliance with ResMed VPAPs

Nursing Care Facilities in US

Nursing Care Facilities - US

Residential Mental Retardation Facilities in US

Residential Mental Retardation Facilities - US

Nursing Care Facilities in UK

Nursing Care Facilities - UK

Results 1-10 of 30
 

Refine by Topic:



Refine by Content Type:

  • Refined by: Products  


Refine by Source:

11 Sources ...